Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.

J Headache Pain · 2022 · PMC9623966 · PMID 36316648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

The combination of UP and UAs for HFEM patients significantly increased ≥ 50% response rate even after correction for multiple comparison, while the same combination is only borderline significant for ≥ 75% response rate.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.